ASCP 2013 Chicago Casts Spotlight on Test Utilization, Personalized Medicine, and Informatics
Monday, September 9, 2013
Two leading pathologists who have been at the center of the national appropriate test utilization debate will share unique perspectives on ways to reduce medical testing costs at ASCP 2013 Chicago, Sept. 18–21, at the Hyatt Regency Chicago.
“Pathologists and laboratory professionals need to engage the medical leadership in their institutions. Hospital administrators, the chief medical and surgical operations officers, and department chairs are usually interested in evaluating best practices, particularly when they also involve cost-savings measures. These individuals are important allies for the system-wide implementation of test utilization initiatives.”
—Gary Procop, MD, FASCP
Elaine Jeter, MD, Medical Director of Palmetto GBA, LLC, one of Medicare’s larger insurance carriers in Columbia, S.C., and Gary Procop, MD, FASCP, Chairman of the Department of Molecular Pathology at the Cleveland Clinic, Cleveland, will headline a session titled, “Putting Pathology and Laboratory Medicine In The Driver’s Seat for Tomorrow’s Healthcare,” moderated by Lee H. Hilborne, MD, MPH, FASCP, DLM(ASCP)CM, Medical Director for Quest Diagnostics in Southern California and Professor of Pathology and Laboratory Medicine at the University of California, Los Angeles. The session will take place Thursday, Sept. 19, from 11:15 a.m. until 12:30 p.m.
The session explores the Choosing Wisely campaign launched by the American Board for Internal Medicine to spark conversations between patients and physicians about what care is really necessary. ASCP is a part of the Choosing Wisely campaign.
Dr. Jeter has been working with Palmetto to craft a reimbursement scheme for molecular testing for the regions of the country that Palmetto services. Dr. Procop led the Cleveland Clinic's successful review process of duplicative testing, now a model for health systems nationwide that demonstrates how a large health system can save money while reducing the volume of tests performed.
“Pathologists and laboratory professionals need to engage the medical leadership in their institutions,” Dr. Procop says. “Hospital administrators, the chief medical and surgical operations officers, and department chairs are usually interested in evaluating best practices, particularly when they also involve cost-savings measures. These individuals are important allies for the system-wide implementation of test utilization initiatives.”
This session is one of three general sessions at ASCP 2013 Chicago that focus on pivotal issues confronting pathology and laboratory medicine amid one of the largest periods of change in health care since Medicare was first formulated.
James Crawford, MD, PhD, FASCP, Senior Vice President of Laboratory Medicine at North Shore-Long Island Jewish Health System in Manhasset, N.Y., will moderate a general session of the annual meeting focusing on patient-centered care, examining topics such as coordinated care, accountable care organizations (ACOs), and value-based medical practices. The panelist is David Nace, MD, Chairman of the Board of Directors of the Patient-Centered Primary Care Collaborative, Washington, D.C. The session will take place on Wednesday, Sept. 18, from 8 a.m. to 9:30 a.m.
The final general session explores the convergence of technology and health care. Mark Tuthill, MD, FASCP, Division Head for Pathology Informatics at the Henry Ford Health System in Detroit and a leader of the Association for Pathology Informatics, will examine how dramatic advances in pathology informatics are transforming personalized medicine and the delivery of patient care. Panelists include clinical informatics pioneers Bruce Friedman, MD, FASCP, and Ulysses Balis, MD, FASCP, both of the University of Michigan, Ann Arbor, Mich. The session is Friday, Sept. 20, from 11:15 a.m. to 12:30 p.m.